🇺🇸 FDA
Pipeline program

MCAM

UTHSCSA-MCAM-101

Phase 1 small_molecule active

Quick answer

MCAM for Opioid Use Disorder is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Opioid Use Disorder
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials